Photosensitizable ZIF-8 BioMOF for Stimuli-Responsive Antimicrobial Phototherapy
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.4c00981 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Angana De und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nanomaterials and Application Technology, Center of Innovative and Applied Bioprocessing (CIAB), Department of Biotechnology (DBT), Gov…. Hauptthemen laut MEDLINE: Photosensitizing Agents, Photochemotherapy, Metal-Organic Frameworks, Anti-Bacterial Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Indian Council of Medical Research, Council of Scientific and Industrial Research, India, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Resistant pathogens are increasingly posing a heightened risk to healthcare systems, leading to a growing concern due to the lack of effective antimicrobial treatments. This has prompted the adoption of antimicrobial photodynamic therapy (aPDT), which eradicates microorganisms by generating reactive oxygen species (ROS) through the utilization of a photosensitizer, photons, and molecular oxygen. However, a challenge arises from the inherent characteristics of photosensitizers, including photobleaching, aggregation, and self-quenching. Consequently, a strategy has been devised to adsorb or bind photosensitizers to diverse carriers to facilitate their delivery. Notably, metal-organic frameworks (MOFs) have emerged as a promising means of transporting photosensitizers, even though achieving uniform particle sizes through room-temperature synthesis remains a complex task. In this work, we have tackled the issue of heterogeneous particle size distribution in MOFs, achieving a particle size of 150 ± 50 nm. Subsequently, we harnessed Zeolite Imidazolate Framework 8 (ZIF-8), an excellent subclass of biocompatible MOF, to effectively load two distinct categories of photosensitizers, namely, Rose Bengal (RB) and porphyrin, using a simple, straightforward, and single-step process. Our findings indicate that the prepared RB@ZIF-8 complex generates a more substantial amount of reactive singlet oxygen species when subjected to photoirradiation (using green light-emitting diode (LED)) at low concentrations, in comparison with porphyrin@ZIF-8, as demonstrated in in vitro experiments. Additionally, we investigated the pH-responsive behavior of the complex to ascertain its implications under biological conditions. Correspondingly, the RB@ZIF-8 complex exhibited a more favorable IC50 value against Escherichia coli compared to bare photosensitizers, ZIF-8 alone, and other photosensitizer-loaded ZIF-8 complexes. This underscores the potential of BioMOF as a promising strategy for combatting multidrug-resistant bacteria across a spectrum of infection scenarios, complemented by its responsiveness to stimuli.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nanomaterials and Application Technology, Center of Innovative and Applied Bioprocessing (CIAB), Department of Biotechnology (DBT), Government of India, Sector 81 (Knowledge City), S.A.S. Nagar, Mohali 140…
- Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
ORCID-Profile: Vamshi Krishna Tippavajhala, Jayeeta Bhaumik
Förderung
- Indian Council of Medical Research
- Council of Scientific and Industrial Research, India
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
De, A., Reddy, Y. N., Paul, S., Sharma, V., Tippavajhala, V. K., & Bhaumik, J. (2025). Photosensitizable ZIF-8 BioMOF for Stimuli-Responsive Antimicrobial Phototherapy. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00981
Vancouver
De A, Reddy YN, Paul S, Sharma V, Tippavajhala VK, Bhaumik J. Photosensitizable ZIF-8 BioMOF for Stimuli-Responsive Antimicrobial Phototherapy. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c00981
BibTeX
@article{De2025,
author = {De, Angana and Reddy, Yeddula Nikhileshwar and Paul, Shatabdi and Sharma, Vaibhav and Tippavajhala, Vamshi Krishna and Bhaumik, Jayeeta},
title = {Photosensitizable ZIF-8 BioMOF for Stimuli-Responsive Antimicrobial Phototherapy},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.4c00981}
}
EUVIMED